SYNA SYNAPTICS Inc
Semiconductors & Related Devices · Nasdaq · SEC CIK 817720 · Fiscal year ends 06/26
Financial factors as of 2026-09-26 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.1%
TTM net income YoY-977.0%
TTM EPS YoY-971.8%
Revenue 3-yr CAGR1.5%
Net income 3-yr CAGR—
Margins
Gross margin46.0%
Operating margin-4.7%
Net margin-40.7%
FCF margin5.4%
EBITDA margin-2.3%
Returns
ROE-42.1%
ROA-21.1%
ROIC (approx.)-2.8%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets55.3%
Debt / equity0.91x
Current ratio1.15x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.21x
Accruals ratio-25.6%
Payout ratio—
Capex / revenue3.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-26 | 2026Q4*2026-06-27 | 2026Q32026-03-28 | 2026Q22025-12-27 | 2026Q12025-09-27 | 2025Q4*2025-06-28 | 2025Q32025-03-29 | 2025Q22024-12-28 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $294.00M | $308.00M | $294.20M | $302.50M | $292.50M | $282.80M | $266.60M | $267.20M |
| Cost of revenue | $153.60M | $162.20M | $160.90M | $170.80M | $167.90M | $161.30M | $150.80M | $145.00M |
| Gross profit | $140.40M | $145.80M | $133.30M | $131.70M | $124.60M | $121.50M | $115.80M | $122.20M |
| R&D expense | $91.00M | $97.80M | $94.50M | $95.10M | $94.40M | $93.60M | $88.60M | $83.30M |
| SG&A expense | $51.70M | $54.70M | $49.60M | $47.80M | $46.20M | $46.10M | $34.70M | $49.50M |
| Operating income | -$12.70M | -$16.10M | -$12.70M | -$15.10M | -$23.20M | -$24.20M | -$26.30M | -$15.20M |
| Interest expense | — | — | — | — | — | $28.50M | $1.10M | $4.30M |
| Pretax income | -$15.50M | -$24.00M | -$15.20M | -$17.50M | -$22.70M | -$25.80M | -$27.40M | -$26.00M |
| Income tax | $2.20M | $423.40M | -$7.20M | -$2.70M | -$2.10M | -$21.10M | -$5.60M | -$27.80M |
| Net income | -$17.70M | -$447.40M | -$8.00M | -$14.80M | -$20.60M | -$4.70M | -$21.80M | $1.80M |
| EBITDA | -$6.50M | -$8.30M | -$4.80M | -$7.50M | -$15.70M | -$17.10M | -$19.10M | -$7.80M |
| EPS (basic) | -0.45 | — | -0.21 | -0.38 | -0.53 | — | -0.56 | 0.05 |
| EPS (diluted) | -0.45 | — | -0.21 | -0.38 | -0.53 | — | -0.56 | 0.05 |
| Weighted avg. shares (diluted) | 39.40M | — | 38.80M | 38.90M | 38.80M | — | 39.00M | 39.80M |
| Balance sheet | ||||||||
| Cash & equivalents | $367.70M | $442.50M | $404.40M | $437.40M | $459.90M | $391.50M | $360.40M | $596.10M |
| Short-term investments | — | $0 | $0 | $0 | $0 | $61.00M | $61.00M | — |
| Receivables | $188.50M | $164.00M | $162.50M | $132.70M | $119.50M | $130.30M | $132.00M | $146.50M |
| Inventory | $184.70M | $156.40M | $161.30M | $158.00M | $143.10M | $139.50M | $132.90M | $119.50M |
| Current assets | $762.10M | $787.00M | $755.40M | $771.00M | $749.00M | $751.90M | $712.60M | $890.50M |
| PP&E, net | $87.00M | $86.90M | $82.50M | $83.10M | $77.40M | $72.10M | $71.00M | $75.30M |
| Goodwill | $872.30M | $872.30M | $872.30M | $872.30M | $872.30M | $872.30M | $872.30M | $819.90M |
| Intangibles | $191.40M | $187.80M | $209.60M | $235.50M | $269.50M | $262.20M | $296.30M | $242.00M |
| Total assets | $2.05B | $2.10B | $2.52B | $2.56B | $2.58B | $2.58B | $2.55B | $2.53B |
| Current liabilities | $664.10M | $701.30M | $248.20M | $263.40M | $262.00M | $270.90M | $247.50M | $229.80M |
| Short-term debt | $440.10M | $439.60M | — | — | — | $0 | — | — |
| Long-term debt | $397.90M | $397.70M | $836.70M | $836.00M | $835.40M | $834.80M | $834.20M | $832.50M |
| Total debt | $838.00M | $837.30M | $836.70M | $836.00M | $835.40M | $834.80M | $834.20M | $832.50M |
| Total liabilities | $1.14B | $1.17B | $1.16B | $1.18B | $1.18B | $1.19B | $1.17B | $1.15B |
| Shareholders' equity | $917.90M | $929.50M | $1.36B | $1.38B | $1.40B | $1.39B | $1.39B | $1.38B |
| Net debt | $470.30M | $394.80M | $432.30M | $398.60M | $375.50M | $443.30M | $473.80M | $236.40M |
| Shares outstanding | 39.70M | 39.06M | 38.74M | 38.71M | 39.10M | 38.64M | 38.85M | 39.18M |
| Cash flow statement | ||||||||
| Operating cash flow | -$15.50M | $67.60M | $21.80M | $29.80M | $30.20M | $57.20M | $73.40M | $22.80M |
| Capital expenditure | $3.10M | $12.30M | $11.90M | $11.60M | $12.20M | $6.60M | $5.40M | $4.70M |
| Free cash flow | -$18.60M | $55.30M | $9.90M | $18.20M | $18.00M | $50.60M | $68.00M | $18.10M |
| Investing cash flow | -$28.10M | -$12.30M | -$11.90M | -$11.60M | $48.80M | -$8.90M | -$274.40M | -$5.50M |
| Financing cash flow | -$30.90M | -$17.60M | -$42.80M | -$40.70M | -$10.40M | -$18.40M | -$34.80M | -$274.70M |
| Depreciation & amortization | $6.20M | $7.80M | $7.90M | $7.60M | $7.50M | $7.10M | $7.20M | $7.40M |
| Stock-based compensation | $37.00M | $34.20M | $39.70M | $38.70M | $36.70M | $31.10M | $19.90M | $34.60M |
| Share buybacks | $0 | $10.10M | $39.00M | $36.40M | $7.20M | $16.00M | $37.80M | $74.50M |
Free plan shows the latest 8 periods; Pro shows all 73 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.